Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diffuse Sclerosis Systemic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05078749
What this trial is testing

The Effects of Telerehabilitation Based Exercise Program in Patients With Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Gazi University 26
Not applicableLooking for participantsNCT06256575
What this trial is testing

Study of Diosmin for the Treatment of Digital Ulcers in Systemic Sclerosis

Who this might be right for
Scleroderma, SystemicDigital Ulcer
Primus Pharmaceuticals 45
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Early research (Phase 1)Active Not RecruitingNCT06255028
What this trial is testing

CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusLupus NephritisIdiopathic Inflammatory Myopathies+1 more
Century Therapeutics, Inc. 6
Testing effectiveness (Phase 2)WithdrawnNCT05098145
What this trial is testing

A Safety and Efficacy Study of FCR001 in Adults With Rapidly Progressive Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Talaris Therapeutics Inc.
Not applicableStudy completedNCT00341198
What this trial is testing

Confirmation of Systemic Autoimmune Diseases in the Agricultural Health Study

Who this might be right for
Autoimmune Disease
National Institute of Environmental Health Sciences (NIEHS) 700
Testing effectiveness (Phase 2)Looking for participantsNCT03211793
What this trial is testing

Mesenchymal Stromal Cells as Treatment for Digital Ulcers in Systemic Sclerosis

Who this might be right for
Systemic SclerosisDigital Ulcer
UMC Utrecht 20
Early research (Phase 1)Ended earlyNCT00282425
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Systemic Sclerosis

Who this might be right for
Scleroderma
Richard Burt, MD 8
Large-scale testing (Phase 3)Looking for participantsNCT06936215
What this trial is testing

Safety and Efficacy of Baricitinib on Skin Tightening in Diffuse Cutaneous Systemic Sclerosis: A Comparative Study With Methotrexate

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 24
Post-approval studies (Phase 4)Study completedNCT07472166
What this trial is testing

Efficacy of Tofacitinib on Skin Thickening in Diffuse Cutaneous Systemic Sclerosis: A Comparative Study With Methotrexate

Who this might be right for
Scleroderma, Systemic
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 34
Early research (Phase 1)Study completedNCT02426229
What this trial is testing

Safety & Suitability of Dabigatran to Inhibit Thrombin in Scleroderma

Who this might be right for
SclerodermaInterstitial Lung Disease
Medical University of South Carolina 15
Testing effectiveness (Phase 2)Ended earlyNCT03740724
What this trial is testing

FCX-013 Plus Veledimex for the Treatment of Moderate to Severe Localized Scleroderma (Morphea)

Who this might be right for
MorpheaScleroderma, LocalizedScleroderma
Castle Creek Biosciences, LLC. 1
Testing effectiveness (Phase 2)Study completedNCT01933334
What this trial is testing

Safety and Tolerability of Pirfenidone in Participants With Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)

Who this might be right for
Systemic Sclerosis
Genentech, Inc. 63
Not applicableUnknownNCT01642706
What this trial is testing

Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic Treatments

Who this might be right for
Rheumatoid ArthritisOsteoarthritisSystemic Lupus Erythematosus+6 more
University Hospital, Montpellier 240
Testing effectiveness (Phase 2)Study completedNCT00764309
What this trial is testing

Safety Evaluation of Dasatinib in Subjects With Scleroderma Pulmonary Fibrosis

Who this might be right for
Scleroderma
Bristol-Myers Squibb 47
Not applicableEnded earlyNCT02851875
What this trial is testing

Duke Scleroderma Clinic Patient Registry

Who this might be right for
SclerodermaSystemic Sclerosis
Duke University 42
Not applicableUnknownNCT04563481
What this trial is testing

Effectiveness of Telerehabilitation on Scleroderma

Who this might be right for
SclerodermaScleroderma, SystemicScleroderma Associated Digital Ulcer+3 more
Istanbul University 32
Testing effectiveness (Phase 2)Study completedNCT00613171
What this trial is testing

Efficacy and Tolerability of STI571 (Imatinib Mesylate) for the Treatment of Fibrosis in Participants With Systemic Sclerosis

Who this might be right for
Systemic Sclerosis, Scleroderma
Novartis Pharmaceuticals 27
Not applicableEnrolling By InvitationNCT02422875
What this trial is testing

Comparative Autoantibody and Immunologic Cell Marker Study

Who this might be right for
Autoimmune DiseasesLupus Erythematosus, SystemicCommunicable Diseases
Emory University 2,500
Large-scale testing (Phase 3)UnknownNCT00428883
What this trial is testing

High Dose Intravenous N-Acetylcysteine Versus Iloprost for Early, Rapidly Progressive Diffuse Systemic Sclerosis

Who this might be right for
Scleroderma, Diffuse
Università Politecnica delle Marche 45
Next Page